Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Evaluation of Biological Modifiers
Berd, David
Fox Chase Cancer Center, Philadelphia, PA, United States
Search 18 grants from David Berd
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Training Grant in Dynamic Aspects of Chemical Biology
Bcm Clinical Site for an Undiagnosed Diseases Network (UDN)
Pheromone Stimulated SST2 Phosphorylation in Yeast
Alzheimers Caregivers - an Attributional Analysis
Coms - Photograph Reading Center
Recently added grants:
Lipid Antigens for iNKT Cells in the Gut Microenvironment
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
Human B1-like Cells and Pneumococcal Defense in the Elderly
Maternal regulation of diet-induced obesity in offspring.
Mechanisms of improved organ function following sepsis treatment with vitamin c, thiamine and hydrocortisone (triple therapy)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007432-001007
Application #
3608443
Study Section
Project Start
1983-09-30
Project End
Budget Start
1986-04-01
Budget End
1986-07-31
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Related projects
NIH 1986
N01 CM
Clinical Evaluation of Biological Modifiers
Berd, David / Fox Chase Cancer Center
NIH 1985
N01 CM
Clinical Evaluation of Biological Modifiers
Berd, David / Fox Chase Cancer Center
Publications
Berd, D; Mastrangelo, M J
(1987)
Depletion of suppressor-cytotoxic T-lymphocytes by administration of a murine monoclonal antibody.
Cancer Res 47:2727-32
Comments
Be the first to comment on this grant